Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Miedema

Showing results (111-120 of 180) with videos related to

Pageof 18
Sort By:
Nature|November 5, 1987
Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidaseR A Gruters, J J Neefjes, M Tersmette, et al.
European Journal of Immunology|May 1, 1988
Anti-CD27 monoclonal antibodies identify two functionally distinct subpopulations within the CD4+ T cell subsetR A Van Lier, M O Pool, P Kabel, et al.
European Journal of Immunology|June 1, 1987
Anti-HLA-class II monoclonal antibodies inhibit polyclonal B cell differentiation in vitro at the accessory cell levelM A De Rie, P Kabel, R W Sauerwein, et al.
Blood|December 23, 1999
T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART)M D Hazenberg, J W Stuart, S A Otto, et al.
The Journal of Infectious Diseases|April 1, 1995
Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levelsE Hogervorst, S Jurriaans, F de Wolf, et al.
Journal of Virology|June 1, 1988
Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complexM Tersmette, R E de Goede, B J Al, et al.
AIDS (London, England)|November 8, 2001
Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strainsJ Goudsmit, G J Weverling, L van der Hoek, et al.
AIDS (London, England)|January 6, 1999
Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapyS Kostense, F M Raaphorst, D W Notermans, et al.
The Journal of Infectious Diseases|November 24, 1999
Treatment with granulocyte colony-stimulating factor decreases the capacity of hematopoietic progenitor cells for generation of lymphocytes in human immunodeficiency virus-infected personsS D Nielsen, D R Clark, M Hutchings, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
Immunologic studies with LFA-1- and Mo1-deficient lymphocytes from a patient with recurrent bacterial infectionsF Miedema, P A Tetteroo, F G Terpstra, et al.
Pageof 18

Showing results (111-120 of 180) with videos related to

Sort By:
Pageof 18
Nature|November 5, 1987
Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidaseR A Gruters, J J Neefjes, M Tersmette, et al.
European Journal of Immunology|May 1, 1988
Anti-CD27 monoclonal antibodies identify two functionally distinct subpopulations within the CD4+ T cell subsetR A Van Lier, M O Pool, P Kabel, et al.
European Journal of Immunology|June 1, 1987
Anti-HLA-class II monoclonal antibodies inhibit polyclonal B cell differentiation in vitro at the accessory cell levelM A De Rie, P Kabel, R W Sauerwein, et al.
Blood|December 23, 1999
T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART)M D Hazenberg, J W Stuart, S A Otto, et al.
The Journal of Infectious Diseases|April 1, 1995
Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levelsE Hogervorst, S Jurriaans, F de Wolf, et al.
Journal of Virology|June 1, 1988
Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complexM Tersmette, R E de Goede, B J Al, et al.
AIDS (London, England)|November 8, 2001
Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strainsJ Goudsmit, G J Weverling, L van der Hoek, et al.
AIDS (London, England)|January 6, 1999
Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapyS Kostense, F M Raaphorst, D W Notermans, et al.
The Journal of Infectious Diseases|November 24, 1999
Treatment with granulocyte colony-stimulating factor decreases the capacity of hematopoietic progenitor cells for generation of lymphocytes in human immunodeficiency virus-infected personsS D Nielsen, D R Clark, M Hutchings, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
Immunologic studies with LFA-1- and Mo1-deficient lymphocytes from a patient with recurrent bacterial infectionsF Miedema, P A Tetteroo, F G Terpstra, et al.
Pageof 18